Company news

Kodiak Sciences Inc news in 2022

Kodiak Sciences Inc's news releases, calls and decks from 2022, newest first.

View company

Kodiak Sciences to Present at the Evercore ISI 5th Annual HealthCONx Conference

November 15, 2022

Kodiak Sciences Announces Third Quarter 2022 Financial Results and Recent Business Highlights

November 8, 2022

Kodiak Sciences to Present at the 2022 Morgan Stanley Healthcare Conference

September 6, 2022

Kodiak Sciences Announces Upcoming Presentations of Tarcocimab Tedromer (KSI-301) Phase 3 BEACON Study Results in Retinal Vein Occlusion (RVO)

August 17, 2022

Kodiak Sciences Announces Second Quarter 2022 Financial Results and Recent Business Highlights

August 8, 2022

Kodiak Sciences Reports Positive Topline Results from BEACON Phase 3 Study of Tarcocimab Tedromer (KSI-301) in Patients with Retinal Vein Occlusion

August 7, 2022

Kodiak Sciences Completes Enrollment in GLOW Phase 3 Clinical Trial of Tarcocimab Tedromer (KSI-301) in Patients with Non-Proliferative Diabetic Retinopathy

August 4, 2022

Kodiak Sciences to Present at the Jefferies Global Healthcare Conference

May 26, 2022

Grand Opening of Kodiak Sciences' Purpose-built Bioconjugation Facility to Support Potential Commercial Manufacture of KSI-301, an Antibody Biopolymer Conjugate for Retinal Diseases

May 18, 2022

Kodiak Sciences Announces First Quarter 2022 Financial Results and Recent Business Highlights

May 9, 2022

Kodiak Sciences Announces Presentation of KSI-301 Phase 2b/3 Study Data in wet AMD at Upcoming Research Conferences

April 28, 2022

Kodiak Sciences Announces Fourth Quarter and Full Year 2021 Financial Results and Recent Business Highlights

February 28, 2022

Kodiak Sciences Announces Top-Line Results from its initial Phase 2b/3 Study of KSI-301 in Patients with Neovascular (Wet) Age-Related Macular Degeneration

February 22, 2022

Kodiak Sciences Completes Enrollment in GLEAM and GLIMMER Phase 3 Clinical Trials of KSI-301 in Patients with Diabetic Macular Edema

February 2, 2022

Kodiak Sciences to Present at the 40th Annual J.P. Morgan Healthcare Conference

January 2, 2022

Decks in 2022